[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.106.138. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 628
Citations 0
Comment & Response
January 27, 2015

Ethical Testing of Experimental Ebola Treatments

Author Affiliations
  • 1School of Population and Public Health, University of British Columbia, Vancouver, Canada
  • 2Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
  • 3Stanford Prevention Research Center, Stanford University, Stanford, California
JAMA. 2015;313(4):421-422. doi:10.1001/jama.2014.17259

To the Editor Dr Joffe1 argued for the importance of randomized study designs to ensure the acquisition of scientific knowledge required for the response to the Ebola epidemic to progress, as well as to ensure ethical treatment of patients. Many calls for RCTs have culminated with the establishment, by the Wellcome Trust, of an international consortium to conduct clinical trials of experimental therapeutics for Ebola virus disease in West Africa.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×